Continuity of Cancer Treatment Amidst the 2026 Gulf Regional Conflict: Insights and a Resilience Model from Gulf States
-
By
-
Humaid O. Al-Shamsi
-
Saeed Rafii
-
Maha Al Sindi
-
Ahmad Alhuraiji
-
Nedal Bukhari
-
Ibrahim Abu-Gheida
-
Deborah Mukherji
-
April 23, 2026
-
Clinical Scorecard: Continuity of Cancer Treatment Amidst the 2026 Gulf Regional Conflict: Insights and a Resilience Model from Gulf States
At a Glance
| Category | Detail |
|---|
| Condition | Cancer care continuity during geopolitical instability |
| Key Mechanisms | Advanced healthcare infrastructure, robust pharmaceutical supply chains, strong governance, skilled workforce, public trust |
| Target Population | Cancer patients in Gulf Cooperation Council (GCC) countries |
| Care Setting | Oncology services in conflict-affected regions |
Key Highlights
- Cancer treatment timelines are critical and cannot be deferred during crises.
- Disruptions in healthcare systems can lead to delayed diagnoses and poorer outcomes.
- Oncology services in UAE, Bahrain, Kuwait, and Saudi Arabia maintained operations with minimal interruption during conflict.
- Resilience factors include advanced infrastructure and stable supply chains.
- Lessons learned can strengthen health system preparedness for future crises.
Guideline-Based Recommendations
Diagnosis
- Ensure timely access to diagnostic services even during conflicts.
Management
- Maintain continuity of chemotherapy and radiotherapy schedules.
Monitoring & Follow-up
- Regularly assess the impact of geopolitical instability on cancer care delivery.
Risks
- Prolonged instability may compromise care quality and patient outcomes.
Patient & Prescribing Data
Cancer patients in the Gulf region, particularly in UAE, Bahrain, Kuwait, and Saudi Arabia.
Continuous access to chemotherapy and radiotherapy is crucial for maintaining treatment efficacy.
Clinical Best Practices
- Invest in advanced healthcare infrastructure to support oncology services.
- Develop robust pharmaceutical supply chains to ensure drug availability.
- Foster strong governance and public trust in healthcare institutions.
References
